Literature DB >> 7637593

Prolonged expression of Fos-related antigens, Jun B and TrkB in dopamine-denervated striatal neurons.

M Dragunow1, N Butterworth, H Waldvogel, R L Faull, L F Nicholson.   

Abstract

Previous studies have demonstrated that striatal dopamine-denervation leads to a long-term increase in Fos-related antigen(s) (FRA's) in striatal neurons. Because Fos-family proteins bind to DNA by dimerizing to Jun-family proteins we investigated the expression of Jun B protein 2 weeks and 1 month after striatal dopamine-denervation, produced by medial forebrain bundle transection. We also investigated the effects of this lesion on TrkB-immunoreactivity in the striatum. FRA's (as previously reported) and Jun B were expressed in striatal neurons following dopamine-denervation, and in addition, there was an increase in expression of TrkB in the striatum on the dopamine-denervated side. These results show that striatal dopamine depletion leads to a long-term up-regulation of FRA's and Jun B in the striatum, and this may be related to other biochemical changes previously reported to occur in striatal neurons (e.g.: D2-dopamine receptor up-regulation) after dopamine depletion. In addition, FRA and Jun B expression may induce increased production of TrkB after dopamine-denervation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637593     DOI: 10.1016/0169-328x(95)00037-s

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements.

Authors:  Xuebing Cao; Toru Yasuda; Subramaniam Uthayathas; Ray L Watts; M Maral Mouradian; Hideki Mochizuki; Stella M Papa
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 2.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

3.  Involvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss.

Authors:  Arman Lira; Jerzy Kulczycki; Ruth Slack; Hymie Anisman; David S Park
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

4.  Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Matthew P Mount; Yi Zhang; Mandana Amini; Steve Callaghan; Jerzy Kulczycki; Zixu Mao; Ruth S Slack; Hymie Anisman; David S Park
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

5.  Immediate early gene expression in rat basal ganglia after destruction of the dopaminergic system.

Authors:  V Pedersen; W J Schmidt
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.

Authors:  Ravi S Akundi; Zhenyu Huang; Joshua Eason; Jignesh D Pandya; Lianteng Zhi; Wayne A Cass; Patrick G Sullivan; Hansruedi Büeler
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.